DOCSLIB.ORG

Data Set 3. Liver-Cell Transcripts 1 Affymetrix Systematic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Data Set 3. Liver-Cell Transcripts 1 Affymetrix Systematic Data Set 3. Liver-cell transcripts 1 Affymetrix systematic Genbank name name Description Dr.2947.1.A1_at AI496754 NA Dr.2945.1.A1_a_at BI707709 NA Dr.2944.1.A1_at BM531153 acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase) Dr.2941.1.S1_at BC049015.1 Brain protein 44. Dr.2956.1.S1_at BC049017.1 H3 histone, family 3A. Dr.2953.2.S1_at CD015569 Sorting nexin 3. Dr.2952.1.S1_at NM_178290.2 Selenoprotein T. Dr.2918.1.S1_at BC044153.1 scaffold attachment factor B Dr.2908.1.A1_at BQ109087 NA Dr.2902.1.S1_at BG306487 NA Dr.2899.1.A1_at AI415936 Similar to RIKEN cDNA 6230416A05 gene. Dr.2951.1.S1_at CD606490 ubiquinol-cytochrome c reductase core protein II Dr.2938.1.S1_at BC044202.1 glutamate dehydrogenase 1 Dr.2931.1.A1_at BI889618 KIAA0251 protein. Dr.2920.1.A1_at AW777460 NA Dr.2992.1.A1_at CD606359 OPA1 protein. Dr.2991.1.A1_at BI983581 NA Dr.2988.1.A1_at BI673378 PGC-1 related co-activator. Dr.2985.1.A1_at AI723156 NA Dr.3020.1.A1_at BM071818 SEC22 vesicle trafficking protein-like 1 (S. cerevisiae) Dr.3005.1.A1_at AW777332 asparagine-linked glycosylation 5 homolog (yeast, dolichyl-phosphate beta- glucosyltransferase) Dr.3004.1.A1_at AW019063 NA Dr.2966.1.A1_at BM534227 Histone acetyltransferase MYST1. Dr.2964.1.S1_at BC050165.1 Cop-coated vesicle membrane protein p24 precursor (p24A). Dr.2961.1.S1_at BI883957 Retinol dehydrogenase. Dr.2960.1.A1_at AA566325 pre-alpha (globulin) inhibitor, H3 polypeptide Dr.3000.1.A1_at AI544756 NA Dr.2979.1.S1_at BC051617.1 NADH:ubiquinone oxidoreductase MLRQ subunit homolog (NUOMS). 2 Dr.2974.1.A1_at AI588098 Hypothetical protein DKFZp686I06147 (Fragment). Dr.2827.1.S1_at BC053120.1 dynactin 2 (p50) Dr.2812.1.A1_at BQ285217 CGI-50 protein. Dr.2810.2.A1_at BG728800 NA Dr.2800.1.A1_at AW420443 NA Dr.284.3.S1_a_at BM956991 ribosomal protein L6 Dr.2839.1.S1_at BC044439.1 NA Dr.2832.1.A1_at BI878464 NA Dr.2784.1.A1_at AI942949 solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 Dr.2779.1.A1_at BM005005 Nedd4 family interacting protein 2 Dr.2778.1.S1_at BC046039.1 syntaxin 4A (placental) Dr.2773.2.A1_at BI891718 NA Dr.2830.1.A1_at BG303780 Hypothetical protein KIAA1142 (Fragment). Dr.280.2.S1_at AL910408 ribosomal protein S20 Dr.280.1.S1_at AF329680.1 Junction plakoglobin. Dr.2790.1.A1_at BM777160 NA Dr.2895.1.S1_at BI888149 NA Dr.2884.1.S1_at AI545004 NA Dr.2876.1.A1_at AW019178 Eukaryotic initiation factor 4B. Dr.2869.1.S1_at BI880088 NA Dr.297.1.S1_at BC047859.1 signal sequence receptor, gamma (translocon-associated protein gamma) Dr.2898.1.A1_at BM024340 FBP-interacting repressor (Siah binding protein 1, FBP interacting repressor, pyrimidine tract binding splicing factor, Ro ribonucleoprotein-binding protein 1). Dr.2897.1.S1_at BC047863.1 ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) Dr.2851.1.A1_at BI891814 Centrosome-associated protein 350 (Hypothetical protein KIAA0480). Dr.2850.1.S1_at BC052136.1 methionine adenosyltransferase II, alpha Dr.2849.1.S1_at AF442500.1 baculoviral IAP repeat-containing 2 Dr.2845.1.A1_at AI965227 NA Dr.2896.1.S1_at BC045301.1 phosphoribosyl pyrophosphate synthetase 1 Dr.2866.1.S1_at BC053254.1 chromosome 6 open reading frame 55 Dr.2863.1.A1_at BM777179 LCLC549. Dr.3226.1.A1_at BI877588 NA 3 Dr.3225.1.A1_at AI878758 glutamate dehydrogenase 1 Dr.3216.1.A1_at AW019173 Hypothetical protein FLJ25678. Dr.321.1.S1_at NM_131309.1 RAN, member RAS oncogene family Dr.324.2.A1_a_at BM103861 adhesion regulating molecule 1 Dr.3237.1.A1_at AI793356 NA Dr.3234.1.A1_at AI723305 Hypothetical protein KIAA0645. Dr.3197.3.A1_x_at AW059155 protocadherin gamma subfamily C, 5 Dr.3197.1.A1_x_at BI671227 protocadherin gamma subfamily C, 5 Dr.3197.1.A1_a_at BI671227 protocadherin gamma subfamily C, 5 Dr.3185.1.A1_at BG306420 NA Dr.323.1.S1_at AI641606 heterogeneous nuclear ribonucleoprotein M Dr.3205.1.S1_at BM402134 cytochrome P450, family 2, subfamily J, polypeptide 2 Dr.3200.1.A1_at AI721919 NA Dr.3198.1.S1_at BI880581 Putative GTP-binding protein PTD004 (PRO2455). Dr.3293.2.A1_at AI878799 NA Dr.3283.1.S1_at BM070482 NA Dr.3280.1.S1_at BC053157.1 WD-repeat protein An11 homolog. Dr.3275.1.A1_at BG306810 glycerol-3-phosphate dehydrogenase 1 (soluble) Dr.3315.1.A1_at AI545303 GCN1 general control of amino-acid synthesis 1-like 1 (yeast) Dr.3307.1.A1_at AW203146 Hypothetical protein FLJ90656. Dr.3305.1.S1_at BC045309.1 ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C. elegans) Dr.3253.1.A1_at BI883218 NA Dr.3248.1.A1_at CD605267 NA Dr.3243.1.A1_at AW117123 Similar to RIKEN cDNA 2410013I23 gene. Dr.3241.1.A1_at BM071310 chromosome 6 open reading frame 111 Dr.330.1.A1_at AI974140 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 Dr.3270.1.S1_at BC048036.1 actin related protein 2/3 complex, subunit 1A, 41kDa Dr.327.1.A1_at AI878797 NA Dr.3073.1.A1_at AI585030 serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 Dr.3054.1.A1_at BI867479 proteasome (prosome, macropain) 26S subunit, ATPase, 4 Dr.3048.1.A1_at AI883274 catenin, beta like 1 Dr.3039.1.A1_at AI477930 NA 4 Dr.3096.1.A1_at BM571916 translocase of inner mitochondrial membrane 17 homolog A (yeast) Dr.3093.1.A1_at AI588368 farnesyltransferase, CAAX box, beta Dr.3090.1.S1_at BC050179.1 NA Dr.3025.2.S1_at BG738204 NA Dr.3025.1.A1_at BM316867 alpha-2-macroglobulin Dr.3023.1.S1_at BM571122 Human full-length cDNA clone CS0DN001YA15 of adult brain of Homo sapiens (Human) (Fragment). Dr.2860.1.S1_at BQ260759 NA Dr.3085.1.A1_at BM101507 Protein disulfide-isomerase A5 precursor (EC 5.3.4.1) (Protein disulfide isomerase-related protein). Dr.3033.2.A1_x_at AA497182 NA Dr.3029.1.A1_at AW019592 UDP glycosyltransferase 1 family, polypeptide A1 Dr.3025.3.S1_at BM530427 alpha-2-macroglobulin Dr.316.1.A1_at AA495481 NA Dr.3143.1.S1_at AI477254 proteasome (prosome, macropain) 26S subunit, ATPase, 3 Dr.3139.1.S1_at BM402142 zinc finger protein 36, C3H type-like 1 Dr.3133.1.A1_at AW019003 NA Dr.3256.1.A1_s_at BG883245 NA Dr.3180.1.A1_at BG306348 basic helix-loop-helix domain containing, class B, 2 Dr.3174.2.A1_at BQ132700 NA Dr.3121.1.A1_at BE017585 NA Dr.3110.1.A1_at BI980047 NA Dr.311.1.S1_at AW777720 Full-length cDNA clone CS0DL002YE04 of B cells (Ramos cell line) of Homo sapiens (human) (Fragment). Dr.3103.1.S1_at BC045463.1 PSMD1 protein (Fragment). Dr.3174.1.A1_at AI722508 NA Dr.3131.1.S1_at BE201867 ribosomal protein S8 Dr.3126.1.S1_at AI626220 mitochondrial ribosomal protein S36 Dr.26301.1.A1_at CD606547 NA Dr.26286.1.A1_at CD606396 NA Dr.26267.1.A1_at CD606280 NA Dr.2625.1.A1_at BQ092506 NA Dr.26322.1.A1_at AI522470 proliferation-associated 2G4, 38kDa 5 Dr.26313.1.A1_at CD606673 NA Dr.26309.1.A1_at CD606605 NA Dr.26148.1.A1_at CD604979 NA Dr.26131.1.S1_at BG303151 KIAA0776 Dr.26126.1.S1_at BC053306.1 Hypothetical protein. Dr.26124.1.A1_at BI878531 NA Dr.26303.1.A1_at CD606560 NA Dr.2621.1.A1_at AI667078 Hypothetical protein FLJ13921. Dr.26192.1.A1_at CD605609 NA Dr.26188.1.A1_at CD605569 NA Dr.26363.1.A1_at AW128181 Programmed cell death 4 (neoplastic transformation inhibitor). Dr.26356.1.S1_at AW165267 Transmembrane protein Tmp21 precursor (21 kDa Transmembrane trafficking protein) (p24delta) (S31III125) (S31I125) (Tmp-21-I). Dr.26355.1.A1_at BM860032 chromosome 6 open reading frame 62 Dr.26353.1.A1_at BG891854 NA Dr.26370.1.S1_at BM861676 Cellular senescence inhibited gene protein. Dr.26369.1.A1_at BI981102 NA Dr.26367.1.A1_at BI840855 NA Dr.26335.1.A1_at AW116194 NA Dr.26329.1.A1_at BG728815 NA Dr.26327.1.A1_at BI883940 NA Dr.26324.1.A1_at CA452365 acetyl-Coenzyme A synthetase 2 (AMP forming)-like Dr.26364.1.A1_at AL917972 NA Dr.26351.1.A1_at AL723765 apoptosis inhibitor 5 Dr.2634.1.A1_at BE605993 NA Dr.25944.1.A1_at CD605564 NA Dr.25917.1.S1_at BI892106 sorting nexin 7 Dr.25913.1.A1_at BI475827 NA Dr.25901.1.A1_at CD605096 NA Dr.26000.1.A1_at CD605897 growth factor receptor-bound protein 10 Dr.25999.1.A1_at CD605896 NA Dr.2596.3.A1_at BI705782 betaine-homocysteine methyltransferase Dr.25880.1.A1_at CD604915 NA 6 Dr.25879.1.A1_at CD604902 NA Dr.25868.1.S1_at BG305824 malate dehydrogenase 2, NAD (mitochondrial) Dr.25864.1.S1_at BC053184.1 chromosome 20 open reading frame 111 Dr.2596.1.S1_a_at BM342901 NA Dr.259.1.S1_at NM_131390.1 glycogen synthase kinase 3 beta Dr.25893.1.A1_at CD605017 NA Dr.25891.1.A1_at CD605001 NA Dr.26096.1.S1_x_at CD581037 2-hydroxyphytanoyl-CoA lyase (EC 4.1.-.-) (2-HPCL) (HSPC279). Dr.26073.1.A1_at CD606460 Hypothetical protein FLJ37651. Dr.26072.1.A1_at CD606459 NA Dr.26051.1.A1_x_at CD606342 NA Dr.26336.1.A1_at AW116556 Hypothetical protein KIAA1604 (Fragment). Dr.26116.1.S1_at BC052971.1 heat shock 70kDa protein 8 Dr.26101.1.A1_at CD606656 NA Dr.26025.1.A1_s_at CD606078 NA Dr.26025.1.A1_at CD606078 NA Dr.26021.1.A1_at CD606052 cullin 4B Dr.2601.1.S1_at BI877937 Hypothetical protein FLJ13340. Dr.261.1.S1_at NM_131263.1 NA Dr.26037.1.A1_at CD606231 NA Dr.26034.1.A1_at CD606187 NA Dr.26544.1.A1_at BE693164 NA Dr.26534.1.A1_at AI721732 NA Dr.26526.1.S1_at AW567065 von Hippel-Lindau binding protein 1 Dr.26522.1.A1_at AI943181 NA Dr.2665.1.A1_at BM101686 NA Dr.2656.1.A1_at AI721427 pyruvate dehydrogenase (lipoamide) alpha 1 Dr.2655.2.A1_at BM316183 Tpr. Dr.26514.1.A1_at AW018983 NFS1 nitrogen fixation 1 (S.
Load more

Recommended publications
  • Association Between C4, C4A, and C4B Copy Number Variations And
    www.nature.com/scientificreports OPEN Association between C4, C4A, and C4B copy number variations and susceptibility to autoimmune Received: 17 June 2016 Accepted: 04 January 2017 diseases: a meta-analysis Published: 16 February 2017 Na Li1, Jun Zhang2, Dan Liao2, Lu Yang2, Yingxiong Wang1 & Shengping Hou2,3 Although several studies have investigated the association between C4, C4A, and C4B gene copy number variations (CNVs) and susceptibility to autoimmune diseases, the results remain inconsistency for those diseases. Thus, in this study, a comprehensive meta-analysis was conducted to assess the role of C4, C4A, and C4B CNVs in autoimmune diseases in different ethnic groups. A total of 16 case-control studies described in 12 articles (8663 cases and 11099 controls) were included in this study. The pooled analyses showed that a low C4 gene copy number (GCN) (<4) was treated as a significant risk factor (odds ratio [OR] = 1.46, 95% confidence interval [CI] = 1.19–1.78) for autoimmune diseases compared with a higher GCN (>4). The pooled statistical results revealed that low C4 (<4) and low C4A (<2) GCNs could be risk factors for systemic lupus erythematosus (SLE) in Caucasian populations. Additionally, the correlation between C4B CNVs and all type of autoimmune diseases could not be confirmed by the current meta-analysis (OR = 1.07, 95% CI = 0.93–1.24). These data suggest that deficiency or absence of C4 and C4A CNVs may cause susceptibility to SLE. The complement system, which is involved in both innate and adaptive immunity, is characterized by triggered-enzyme cascades activated by alternative, lectin or classical pathways1.
    [Show full text]
  • An Order Estimation Based Approach to Identify Response Genes
    AN ORDER ESTIMATION BASED APPROACH TO IDENTIFY RESPONSE GENES FOR MICRO ARRAY TIME COURSE DATA A Thesis Presented to The Faculty of Graduate Studies of The University of Guelph by ZHIHENG LU In partial fulfilment of requirements for the degree of Doctor of Philosophy September, 2008 © Zhiheng Lu, 2008 Library and Bibliotheque et 1*1 Archives Canada Archives Canada Published Heritage Direction du Branch Patrimoine de I'edition 395 Wellington Street 395, rue Wellington Ottawa ON K1A0N4 Ottawa ON K1A0N4 Canada Canada Your file Votre reference ISBN: 978-0-494-47605-5 Our file Notre reference ISBN: 978-0-494-47605-5 NOTICE: AVIS: The author has granted a non­ L'auteur a accorde une licence non exclusive exclusive license allowing Library permettant a la Bibliotheque et Archives and Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par Plntemet, prefer, telecommunication or on the Internet, distribuer et vendre des theses partout dans loan, distribute and sell theses le monde, a des fins commerciales ou autres, worldwide, for commercial or non­ sur support microforme, papier, electronique commercial purposes, in microform, et/ou autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriete du droit d'auteur ownership and moral rights in et des droits moraux qui protege cette these. this thesis. Neither the thesis Ni la these ni des extraits substantiels de nor substantial extracts from it celle-ci ne doivent etre imprimes ou autrement may be printed or otherwise reproduits sans son autorisation.
    [Show full text]
  • WO 2016/147053 Al 22 September 2016 (22.09.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/147053 Al 22 September 2016 (22.09.2016) P O P C T (51) International Patent Classification: (71) Applicant: RESVERLOGIX CORP. [CA/CA]; 300, A61K 31/551 (2006.01) A61P 37/02 (2006.01) 4820 Richard Road Sw, Calgary, AB, T3E 6L1 (CA). A61K 31/517 (2006.01) C07D 239/91 (2006.01) (72) Inventors: WASIAK, Sylwia; 431 Whispering Water (21) International Application Number: Trail, Calgary, AB, T3Z 3V1 (CA). KULIKOWSKI, PCT/IB20 16/000443 Ewelina, B.; 31100 Swift Creek Terrace, Calgary, AB, T3Z 0B7 (CA). HALLIDAY, Christopher, R.A.; 403 (22) International Filing Date: 138-18th Avenue SE, Calgary, AB, T2G 5P9 (CA). GIL- 10 March 2016 (10.03.2016) HAM, Dean; 249 Scenic View Close NW, Calgary, AB, (25) Filing Language: English T3L 1Y5 (CA). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (30) Priority Data: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, 62/132,572 13 March 2015 (13.03.2015) US BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 62/264,768 8 December 2015 (08. 12.2015) US DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, [Continued on nextpage] (54) Title: COMPOSITIONS AND THERAPEUTIC METHODS FOR THE TREATMENT OF COMPLEMENT-ASSOCIATED DISEASES (57) Abstract: The invention comprises methods of modulating the complement cascade in a mammal and for treating and/or preventing diseases and disorders as sociated with the complement pathway by administering a compound of Formula I or Formula II, such as, for example, 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)- 5,7-dimethoxyquinazolin-4(3H)-one or a pharmaceutically acceptable salt thereof.
    [Show full text]
  • Anti-C4B Monoclonal Antibody, Clone FQS3001(3) (DCABH-5883) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-C4B monoclonal antibody, clone FQS3001(3) (DCABH-5883) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Rabbit monoclonal to C4 Antigen Description This gene encodes the basic form of complement factor 4, part of the classical activation pathway. The protein is expressed as a single chain precursor which is proteolytically cleaved into a trimer of alpha, beta, and gamma chains prior to secretion. The trimer provides a surface for interaction between the antigen-antibody complex and other complement components. The alpha chain may be cleaved to release C4 anaphylatoxin, a mediator of local inflammation. Deficiency of this protein is associated with systemic lupus erythematosus. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. Varying haplotypes of this gene cluster exist, such that individuals may have 1, 2, or 3 copies of this gene. In addition, this gene exists as a long form and a short form due to the presence or absence of a 6.4 kb endogenous HERV-K retrovirus in intron 9. This GeneID and its associated RefSeq record represent a second copy of C4B found on ALT_REF_LOCI_7. Immunogen Synthetic peptide within Human C4 aa 1200-1300 (Cysteine residue). The exact sequence is proprietary. Note: this sequence is identical in both C4 subunits A (P0C0L4) and B (P0C0L5).Database link: P0C0L4 Isotype IgG Source/Host Rabbit Species Reactivity Human Clone FQS3001(3) Purity Tissue culture supernatant Conjugate Unconjugated Applications WB, ICC/IF Positive Control HepG2 cell lysate, HepG2 cells Format Liquid Size 100 μl 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Buffer pH: 7.20; Preservative: 0.01% Sodium azide; Constituents: 49% PBS, 50% Glycerol, 0.05% BSA Preservative 0.01% Sodium Azide Storage Store at +4°C short term (1-2 weeks).
    [Show full text]
  • Differential Patterns of Allelic Loss in Estrogen Receptor-Positive Infiltrating Lobular and Ductal Breast Cancer
    GENES, CHROMOSOMES & CANCER 47:1049–1066 (2008) Differential Patterns of Allelic Loss in Estrogen Receptor-Positive Infiltrating Lobular and Ductal Breast Cancer L. W. M. Loo,1 C. Ton,1,2 Y.-W. Wang,2 D. I. Grove,2 H. Bouzek,1 N. Vartanian,1 M.-G. Lin,1 X. Yuan,1 T. L. Lawton,3 J. R. Daling,2 K. E. Malone,2 C. I. Li,2 L. Hsu,2 and P.L. Porter1,2,3* 1Division of Human Biology,Fred Hutchinson Cancer Research Center,Seattle,WA 2Division of Public Health Sciences,Fred Hutchinson Cancer Research Center,Seattle,WA 3Departmentof Pathology,Universityof Washington,Seattle,WA The two main histological types of infiltrating breast cancer, lobular (ILC) and the more common ductal (IDC) carcinoma are morphologically and clinically distinct. To assess the molecular alterations associated with these breast cancer subtypes, we conducted a whole-genome study of 166 archival estrogen receptor (ER)-positive tumors (89 IDC and 77 ILC) using the Affy- metrix GeneChip® Mapping 10K Array to identify sites of loss of heterozygosity (LOH) that either distinguished, or were shared by, the two phenotypes. We found single nucleotide polymorphisms (SNPs) of high-frequency LOH (>50%) common to both ILC and IDC tumors predominately in 11q, 16q, and 17p. Overall, IDC had a slightly higher frequency of LOH events across the genome than ILC (fractional allelic loss 5 0.186 and 0.156). By comparing the average frequency of LOH by chro- mosomal arm, we found IDC tumors with significantly (P < 0.05) higher frequency of LOH on 3p, 5q, 8p, 9p, 20p, and 20q than ILC tumors.
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • DOI: 10.2478/V10129-011-0033-Y
    PLANT BREEDING AND SEED SCIENCE Volume 64 2011 DOI: 10.2478/v10129-011-0033-y Wolfgang Schweiger 1,* , Barbara Steiner 2, Apinun Limmongkon 2, Kurt Brunner 3, Marc Lemmens 2, Franz Berthiller 4, Hermann Bürstmayr 2, Gerhard Adam 1 1Department of Applied Genetics and Cell Biology, University of Natural Resources and Applied Life Sciences, A-1190 Vienna, Austria; 2Institute of Biotechnology in Plant Production, Department of Agrobiotechnology, University of Natural Resources and Applied Life Sciences, A-3430 Tulln, Austria; 3Institute of Chemical Engineering, Vienna University of Technology, A-1060 Vienna, Austria; 4Center for Analytical Chemistry, Depart- ment of Agrobiotechnology, University of Natural Resources and Applied Life Sciences, A-3430 Tulln, Austria; * Author to whom correspondence should be addressed. e-mail: [email protected] ; CLONING AND HETEROLOGOUS EXPRESSION OF CANDIDATE DON-INACTIVATING UDP-GLUCOSYLTRANFERASES FROM RICE AND WHEAT IN YEAST ABSTRACT Fusarium graminearum and related species causing Fusarium head blight of cereals and ear rot of maize produce the trichothecene toxin and virulence factor deoxynivalenol (DON). Plants can detoxify DON to a variable extent into deoxynivalenol-3-O-glucoside (D3G). We have previously reported the DON inactivat- ing glucosyltransferase (UGT) AtUGT73C5 from Arabidopsis thaliana (Poppenberger et al , 2003). Our goal was to identify UGT genes from monocotyledonous crop plants with this enzymatic activity. The two selected rice candidate genes with the highest sequence similarity with AtUGT73C5 were expressed in a toxin sensitive yeast strain but failed to protect against DON. A full length cDNA clone corresponding to a transcript derived fragment (TDF108) from wheat, which was reported to be specifically expressed in wheat genotypes contain- ing the quantitative trait locus Qfhs.ndsu-3BS for Fusarium spreading resistance (Steiner et al , 2009) was reconstructed.
    [Show full text]
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
    [Show full text]
  • Ijms-20-05263-V2
    Delft University of Technology Leloir Glycosyltransferases in Applied Biocatalysis A Multidisciplinary Approach Mestrom, Luuk; Przypis, Marta; Kowalczykiewicz, Daria; Pollender, André; Kumpf, Antje; Marsden, Stefan R.; Szymańska, Katarzyna; Hanefeld, Ulf; Hagedoorn, Peter Leon; More Authors DOI 10.3390/ijms20215263 Publication date 2019 Document Version Final published version Published in International Journal of Molecular Sciences Citation (APA) Mestrom, L., Przypis, M., Kowalczykiewicz, D., Pollender, A., Kumpf, A., Marsden, S. R., Szymańska, K., Hanefeld, U., Hagedoorn, P. L., & More Authors (2019). Leloir Glycosyltransferases in Applied Biocatalysis: A Multidisciplinary Approach. International Journal of Molecular Sciences, 20(21), [5263]. https://doi.org/10.3390/ijms20215263 Important note To cite this publication, please use the final published version (if applicable). Please check the document version above. Copyright Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons. Takedown policy Please contact us and provide details if you believe this document breaches copyrights. We will remove access to the work immediately and investigate your claim. This work is downloaded from Delft University of Technology. For technical reasons the number of authors shown on this cover page is limited to a maximum of 10. International Journal of Molecular Sciences Review Leloir Glycosyltransferases in Applied Biocatalysis: A Multidisciplinary Approach Luuk Mestrom 1, Marta Przypis 2,3 , Daria Kowalczykiewicz 2,3, André Pollender 4 , Antje Kumpf 4,5, Stefan R. Marsden 1, Isabel Bento 6, Andrzej B.
    [Show full text]
  • An Investigation of the Contribution of Centrosomal Genes to Schizophrenia and Cognitive Function
    Provided by the author(s) and NUI Galway in accordance with publisher policies. Please cite the published version when available. Title An investigation of the contribution of centrosomal genes to schizophrenia and cognitive function Author(s) Flynn, Mairéad Publication Date 2020-03-11 Publisher NUI Galway Item record http://hdl.handle.net/10379/15846 Downloaded 2021-09-25T16:18:14Z Some rights reserved. For more information, please see the item record link above. An investigation of the contribution of centrosomal genes to schizophrenia and cognitive function By Mairéad Flynn, B.Sc. A thesis submitted for the Degree of Doctor of Philosophy to the Discipline of Biochemistry, School of Natural Sciences, National University of Ireland, Galway. Supervisor: Dr Derek Morris Discipline of Biochemistry, School of Natural Sciences, National University of Ireland, Galway Co-Supervisor: Prof Ciaran Morrison Discipline of Biochemistry, School of Natural Sciences, National University of Ireland, Galway August 2019 Table of Contents Table of Contents Table of Contents ............................................................................................................. I Declaration .................................................................................................................... VI Statement of Contribution ......................................................................................... VII Acknowledgements .................................................................................................... VIII List
    [Show full text]
  • Supporting Information for Proteomics DOI 10.1002/Prca.200780101
    Supporting Information for Proteomics DOI 10.1002/prca.200780101 Paul Cutler, Emma L. Akuffo, Wanda M. Bodnar, Deborah M. Briggs, John B. Davis, Christine M. Debouck, Steven M. Fox, Rachel A. Gibson, Darren A. Gormley, Joanna D. Holbrook, A. Jacqueline Hunter, Emma E. Kinsey, Rabinder Prinjha, Jill C. Richardson, Allen D. Roses, Marjorie A. Smith, Nikos Tsokanas, David R. Will, Wen Wu, John W. Yates and Israel S. Gloger Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer’s disease in human plasma ª 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.clinical.proteomics-journal.com Supplementary Table 1: Complete list of proteins identified from spots derived from 2D gel analysis of human plasma. Each protein was observed to be in a spot showing altered expression between Alzheimer’s disease and matched control by statistical methods as described in the Methods section. Each protein is identified by the gene description and the HUGO gene symbol. The number of “changing” spots in which this protein was observed is also given. HUGO Human Gene Number of Gene Description Symbol Spots alpha-1-B glycoprotein; A1BG 5 alpha-2-macroglobulin A2M 7 afamin; AFM 1 angiotensinogen (serpin peptidase inhibitor, clade A, member 8) AGT 4 alpha-2-HS-glycoprotein AHSG 3 albumin ALB 90 alpha-1-microglobulin/bikunin precursor; AMBP 1 annexin A1 ANXA1 1 amyloid P component, serum APCS 3 apolipoprotein A-I APOA1 14 apolipoprotein A-IV APOA4 2 apolipoprotein E APOE 2 apolipoprotein
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]